Jerome A. Halperin, who in April retired as executive vice president and

chief executive officer of the United States Pharmacopeia (USP), an

organization that establishes state-of-the-art standards to ensure the

quality of medicines for human and veterinary use nationwide, is the

keynote speaker for Western University of Health Sciences’ 19th annual

commencement ceremony.

Halperin will help launch the University’s graduating students – including

63 members of the College of Pharmacy’s first-ever graduating class – at

ceremonies beginning at 1 p.m. on Friday, June 2, at the Anaheim

Convention Center.

Three hundred and ninety-five candidates for graduation from six Western

University programs will hear Halperin speak on “”Four Rules.”” His

presentation will focus on the values he believes health professionals

should hold as they progress through their careers.

“”I’m pleased and honored to be Western University’s 19th commencement

speaker and the first commencement speaker for its College of Pharmacy,””

Halperin said.

“”Western University is a post-graduate university that integrates the

curricula of its programs in a manner that assures that each health

professional understands and appreciates the role of the other members of

the health care team. This integration breeds interdependency and raises

the skills of each health professional, thus creating the maximum

opportunity to achieve the desired health outcome to the patient. Western

University has established an educational model that works in a patient’s

best interest.””

Western University President Philip Pumerantz, PhD, said Halperin was

chosen to give the commencement address because “”he embodies Western

University’s vision and values: leadership, innovation and

interdisciplinarity. As a pharmacist, no one is better suited to provide a

commencement address to our students, especially the charter class of

graduates from our College of Pharmacy.””

Halperin graduated with a bachelor of science degree from Rutgers, the

State University of New Jersey, and earned a master of public health

degree from the Johns Hopkins School of Hygiene and Public Health, as well

as a master of science in management from MIT, where he was a Sloan Fellow.

He served for 25 years as a commissioned officer in the U.S. Public Health

Service, as a pharmacist and a radiological health specialist. He joined

the FDA Bureau of Drugs in 1974 and became deputy director in 1977. From

1982-83 he served as director of drugs of the (then) National Center for

Drugs and Biologics. He retired from Federal service as a rear admiral and

became vice president, technology, for CIBA Consumer Pharmaceuticals.

Halperin joined the USP in 1989 and became its CEO in March 1990.

He is a Fellow of the American Pharmaceutical Association, the American

Association of Pharmaceutical Scientists, the American Association for the

Advancement of Science, and the American Public Health Association. He

served for 10 years as a member of the World Health Organization’s (WHO)

Expert Advisory Panel on the International Pharmacopoeia and

Pharmaceutical Preparations and he is an Expert Member of the Board of

Pharmaceutical Sciences of the International Federation of Pharmacy (FIP).

He has served on the boards of directors of the American Foundation for

Pharmaceutical Education and the Food and Drug Law Institute, as well as

the board of the National Council for Patient Information and Education,

the American Foundation for Pharmaceutical Education, the advisory board

of several colleges of pharmacy, and numerous other professional

associations in pharmacy and science.